Both in Pharmaceuticals
Altimmune vs Prothena
Over the past year ALT returned −46.3% and PRTA returned −16.5%; their daily moves had a correlation of 0.32.
ALT −46.3% PRTA −16.5%Growth of $1, one year, split-adjusted
| Metric | ALT | PRTA |
|---|---|---|
| Price | $2.12 | $8.20 |
| Market cap | $412.4M | $421.0M |
| Today | −2.30% | −0.61% |
| 1 month | −30.3% | −1.4% |
| 6 months | −25.6% | −23.7% |
| Year to date | −41.3% | −14.1% |
| 1 year | −45.6% | −17.0% |
| Revenue growth (YoY) | −100.0% | −77.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −1839.9% |
| P/E (TTM) | — | — |
| Price / sales | 13,302.5× | 7.7× |
| Net cash | $291.5M | $288.2M |
| Dividend yield | — | — |
| Volatility (60d) | 48.1% | 44.4% |
| Short % of float | 25.1% | 19.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).